The Trump administration and U.K.-based pharmaceutical giant AstraZeneca announced a landmark agreement Friday aimed at lowering prescription drug costs in the United States, marking another step in the administration’s ongoing push to make American medications more affordable. Under the deal, AstraZeneca will…
